Product Program year 2025 Source: CMS Open Payments

Cytogam

Drug Infections and Infectious Diseases

Open in the dashboard

General payments

$26,730

102 payments

Research payments

$307,298

3 payments

Through program year 2025, $26,730 in general payments and $307,298 in research payments were reported against Cytogam (Infections and Infectious Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $26,730 102
2025 Research $307,298 3

Breakdown

Who paid General payments · program year 2025
  1. Kamada Ltd. $26,730 102 payments
Top recipients General payments · program year 2025
  1. Erika Lease Pulmonary Disease · Seattle, WA $5,100 19% · 1 payment
  2. Marcus Pereira Infectious Disease · New York, NY $4,946 19% · 2 payments
  3. Camille Kotton Infectious Disease · Boston, MA $3,570 13% · 1 payment
  4. Lara Danziger-Isakov Pediatric Infectious Diseases · Cincinnati, OH $3,570 13% · 1 payment
  5. Martin Zamora Critical Care Medicine · Orlando, FL $2,800 10% · 7 payments

The top 5 of 77 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pulmonary Disease Internal Medicine $9,306 35% · 22 practitioners
  2. Infectious Disease Internal Medicine $8,823 33% · 5 practitioners
  3. Pediatric Infectious Diseases Pediatrics $3,666 14% · 4 practitioners
  4. Critical Care Medicine Internal Medicine $3,151 12% · 5 practitioners
  5. Nephrology Internal Medicine $331 1% · 6 practitioners

The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Ohio $5,874 22% · 5 recipients
  2. Washington $5,228 20% · 2 recipients
  3. New York $5,214 20% · 7 recipients
  4. Florida $3,894 15% · 11 recipients
  5. Massachusetts $3,693 14% · 4 recipients

The top 5 of 19 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

102 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record